• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡波西肉瘤炎性细胞因子综合征(KICS):一种罕见但可能可治疗的病症。

Kaposi Sarcoma Inflammatory Cytokine Syndrome (KICS): A Rare but Potentially Treatable Condition.

作者信息

Karass Michael, Grossniklaus Emily, Seoud Talal, Jain Sanjay, Goldstein Daniel A

机构信息

New York Medical College, Valhalla, New York, USA

Emory University, Atlanta, Georgia, USA.

出版信息

Oncologist. 2017 May;22(5):623-625. doi: 10.1634/theoncologist.2016-0237. Epub 2017 Apr 19.

DOI:10.1634/theoncologist.2016-0237
PMID:28424322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5423516/
Abstract

Kaposi sarcoma inflammatory cytokine syndrome (KICS) is a newly-described condition affecting individuals who are HIV-positive and are infected with human herpesvirus 8 (HHV-8). This is a syndrome that in some ways mimics severe sepsis with associated acute respiratory distress syndrome, possibly requiring a ventilator and vasopressor support. However, unlike severe sepsis, antibiotics provide no benefit. Management of KICS has not been fully elucidated because of its high mortality rate. However, the syndrome has been successfully treated in some cases with immunomodulatory therapy. It is crucial for oncologists to be able to recognize this syndrome and to institute the appropriate therapy. 2017;22:623-625.

摘要

卡波西肉瘤炎性细胞因子综合征(KICS)是一种新描述的病症,影响HIV阳性且感染人疱疹病毒8(HHV - 8)的个体。这是一种在某些方面类似于伴有急性呼吸窘迫综合征的严重脓毒症的综合征,可能需要呼吸机和血管活性药物支持。然而,与严重脓毒症不同,抗生素并无益处。由于其高死亡率,KICS的管理尚未完全阐明。然而,该综合征在一些病例中已通过免疫调节疗法成功治疗。肿瘤学家能够识别这种综合征并进行适当治疗至关重要。2017年;22:623 - 625。

相似文献

1
Kaposi Sarcoma Inflammatory Cytokine Syndrome (KICS): A Rare but Potentially Treatable Condition.卡波西肉瘤炎性细胞因子综合征(KICS):一种罕见但可能可治疗的病症。
Oncologist. 2017 May;22(5):623-625. doi: 10.1634/theoncologist.2016-0237. Epub 2017 Apr 19.
2
Clinical and pathological features of Kaposi sarcoma herpesvirus-associated inflammatory cytokine syndrome.卡波西肉瘤疱疹病毒相关炎症细胞因子综合征的临床和病理特征。
AIDS. 2020 Nov 15;34(14):2097-2101. doi: 10.1097/QAD.0000000000002669.
3
Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS).有症状的卡波西肉瘤疱疹病毒(KSHV)相关炎症患者的临床特征和结局:KSHV炎性细胞因子综合征(KICS)的前瞻性特征分析
Clin Infect Dis. 2016 Mar 15;62(6):730-738. doi: 10.1093/cid/civ996. Epub 2015 Dec 12.
4
Successful Treatment of Kaposi Sarcoma-Associated Herpesvirus Inflammatory Cytokine Syndrome After Kidney-Liver Transplant: Correlations With the Human Herpesvirus 8 miRNome and Specific T Cell Response.肾肝联合移植后成功治疗卡波西肉瘤相关疱疹病毒炎症细胞因子综合征:与人类疱疹病毒 8 microRNA 组和特异性 T 细胞反应的相关性。
Am J Transplant. 2017 Nov;17(11):2963-2969. doi: 10.1111/ajt.14346. Epub 2017 Jun 27.
5
A Fatal Case of Kaposi Sarcoma Immune Reconstitution Syndrome (KS-IRIS) Complicated by Kaposi Sarcoma Inflammatory Cytokine Syndrome (KICS) or Multicentric Castleman Disease (MCD): A Case Report and Review.一例致命性卡波西肉瘤免疫重建综合征(KS-IRIS)合并卡波西肉瘤炎性细胞因子综合征(KICS)或多中心Castleman病(MCD)的病例报告及文献复习
Am J Case Rep. 2020 Dec 3;21:e926433. doi: 10.12659/AJCR.926433.
6
Omega-3 decreases IL-6 levels in HIV and human herpesvirus-8 coinfected patients in Uganda.ω-3 脂肪酸可降低乌干达 HIV 和人类疱疹病毒-8 合并感染患者的 IL-6 水平。
AIDS. 2018 Feb 20;32(4):505-512. doi: 10.1097/QAD.0000000000001722.
7
Kaposi Sarcoma Herpesvirus Inflammatory Cytokine Syndrome-like Clinical Presentation in Human Immunodeficiency Virus-infected Children in Malawi.马拉维人类免疫缺陷病毒感染儿童中卡波西肉瘤疱疹病毒炎性细胞因子综合征样临床表现
Clin Infect Dis. 2019 Nov 13;69(11):2022-2025. doi: 10.1093/cid/ciz250.
8
Donor-derived human herpesvirus 8 infection with Kaposi sarcoma and Kaposi sarcoma inflammatory cytokine syndrome in a heart transplant recipient: A case report.供体源性人疱疹病毒 8 感染导致心脏移植受者卡波西肉瘤和卡波西肉瘤炎症细胞因子综合征:1 例报告。
Transpl Infect Dis. 2021 Aug;23(4):e13609. doi: 10.1111/tid.13609. Epub 2021 Apr 24.
9
Successful treatment of an HIV-positive patient with unmasking Kaposi's sarcoma immune reconstitution inflammatory syndrome.成功治疗一名 HIV 阳性患者的卡波西肉瘤免疫重建炎症综合征。
J Clin Virol. 2013 Jul;57(3):282-5. doi: 10.1016/j.jcv.2013.03.005. Epub 2013 Apr 8.
10
Editorial commentary: treatment of Kaposi sarcoma in the highly active antiretroviral therapy era.编辑评论:高效抗逆转录病毒治疗时代的卡波西肉瘤治疗
Clin Infect Dis. 2008 Aug 1;47(3):418-20. doi: 10.1086/589866.

引用本文的文献

1
Cardiac Kaposi Sarcoma Complicated by Kaposi Sarcoma Inflammatory Cytokine Syndrome: A Case Report.心脏卡波西肉瘤合并卡波西肉瘤炎性细胞因子综合征:一例报告
Cureus. 2025 Jan 5;17(1):e76972. doi: 10.7759/cureus.76972. eCollection 2025 Jan.
2
The Role of vIL-6 in KSHV-Mediated Immune Evasion and Tumorigenesis.病毒白细胞介素-6在卡波西肉瘤相关疱疹病毒介导的免疫逃逸和肿瘤发生中的作用
Viruses. 2024 Dec 10;16(12):1900. doi: 10.3390/v16121900.
3
Diagnosis and Management of Kaposi Sarcoma-Associated Herpesvirus Inflammatory Cytokine Syndrome in Resource-Constrained Settings: A Case Report and an Adapted Case Definition.资源受限环境下卡波西肉瘤相关疱疹病毒炎性细胞因子综合征的诊断与管理:一例病例报告及修订的病例定义
Trop Med Infect Dis. 2024 Dec 16;9(12):307. doi: 10.3390/tropicalmed9120307.
4
Identifying the amino acid domains of ORF59 responsible for interactions with ORF57 and PAN RNA during KSHV lytic replication.确定在卡波西肉瘤相关疱疹病毒(KSHV)裂解复制过程中,ORF59与ORF57和PAN RNA相互作用的氨基酸结构域。
Microbiol Spectr. 2024 Oct 21;12(12):e0116324. doi: 10.1128/spectrum.01163-24.
5
Kaposi sarcoma in an individual recently diagnosed with HIV.一名近期被诊断出感染艾滋病毒的个体患有卡波西肉瘤。
IDCases. 2024 Apr 15;36:e01961. doi: 10.1016/j.idcr.2024.e01961. eCollection 2024.
6
Unusual Localization of AIDS-Related Kaposi's Sarcoma in a Heterosexual Male during the COVID-19 Pandemic: A Case Report.COVID-19大流行期间一名异性恋男性艾滋病相关卡波西肉瘤的罕见定位:病例报告
Trop Med Infect Dis. 2024 Feb 13;9(2):47. doi: 10.3390/tropicalmed9020047.
7
A Challenging Case of Kaposi Sarcoma Inflammatory Cytokine Syndrome.卡波西肉瘤炎性细胞因子综合征的一个具有挑战性的病例。
Cureus. 2023 Jul 20;15(7):e42218. doi: 10.7759/cureus.42218. eCollection 2023 Jul.
8
Targeting Kaposi's sarcoma associated herpesvirus encoded protease (ORF17) by a lysophosphatidic acid molecule for treating KSHV associated diseases.通过溶血磷脂酸分子靶向卡波西肉瘤相关疱疹病毒编码的蛋白酶(ORF17)来治疗卡波西肉瘤相关疱疹病毒相关疾病。
Front Cell Dev Biol. 2023 Jan 17;11:1060156. doi: 10.3389/fcell.2023.1060156. eCollection 2023.
9
Disseminated Kaposi Sarcoma.播散性卡波西肉瘤
Clin Cosmet Investig Dermatol. 2022 Aug 20;15:1711-1714. doi: 10.2147/CCID.S376060. eCollection 2022.
10
Molecular Mechanisms of Kaposi Sarcoma Development.卡波西肉瘤发生的分子机制
Cancers (Basel). 2022 Apr 7;14(8):1869. doi: 10.3390/cancers14081869.

本文引用的文献

1
Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS).有症状的卡波西肉瘤疱疹病毒(KSHV)相关炎症患者的临床特征和结局:KSHV炎性细胞因子综合征(KICS)的前瞻性特征分析
Clin Infect Dis. 2016 Mar 15;62(6):730-738. doi: 10.1093/cid/civ996. Epub 2015 Dec 12.
2
Kaposi sarcoma-associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment.卡波西肉瘤相关疱疹病毒相关恶性肿瘤:流行病学、发病机制及治疗进展
Semin Oncol. 2015 Apr;42(2):223-46. doi: 10.1053/j.seminoncol.2014.12.027. Epub 2014 Dec 31.
3
Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.利妥昔单抗联合脂质体阿霉素治疗合并卡波西肉瘤相关多中心Castleman病的HIV感染患者。
Blood. 2014 Dec 4;124(24):3544-52. doi: 10.1182/blood-2014-07-586800. Epub 2014 Oct 20.
4
Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome.卡波西肉瘤疱疹病毒裂解激活的临床表现:多中心性Castleman病(KSHV-MCD)和KSHV炎性细胞因子综合征。
Front Microbiol. 2012 Mar 2;3:73. doi: 10.3389/fmicb.2012.00073. eCollection 2012.
5
An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.卡波西肉瘤相关疱疹病毒和 HIV 合并感染但无多中心性 Castleman 病患者的白细胞介素 6 相关全身性炎症综合征。
Clin Infect Dis. 2010 Aug 1;51(3):350-8. doi: 10.1086/654798.
6
HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal.人类免疫缺陷病毒/获得性免疫缺陷综合征:免疫重建炎症综合征:重新评估
Clin Infect Dis. 2009 Jan 1;48(1):101-7. doi: 10.1086/595006.
7
Immune reconstitution inflammatory syndrome: risk factors and treatment implications.免疫重建炎症综合征:危险因素及治疗意义
J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):456-62. doi: 10.1097/qai.0b013e3181594c8c.
8
Primary effusion lymphoma.原发性渗出性淋巴瘤
Oncologist. 2007 May;12(5):569-76. doi: 10.1634/theoncologist.12-5-569.
9
Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort.在一个种族多样化的1型艾滋病毒感染队列中免疫重建炎症综合征的发病率及危险因素
Clin Infect Dis. 2006 Feb 1;42(3):418-27. doi: 10.1086/499356. Epub 2005 Dec 28.
10
Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy.1型人类免疫缺陷病毒感染合并结核病患者在开始抗逆转录病毒治疗后免疫重建炎症综合征的决定因素
Clin Infect Dis. 2004 Dec 1;39(11):1709-12. doi: 10.1086/425742. Epub 2004 Nov 9.